Advanced gene editing technique helps patients with previously untreatable form of leukemia
Alyssa Tapley was the first patient to undergo a new gene therapy called BE-CAR7 for her T-cell acute lymphoblastic leukemia, a previously untreatable form of cancer. She has been cancer-free for more than three years. (Image credit – University College of London) CANCER DIGEST – Dec. 27, 2025 – Using a more precise genetic editing technique researchers at the University College of Lindon, in the United Kingdom have developed an advanced form of CAR-T cell therapy that has el
New protocol opens marrow and stem cell transplantation to many more patients with blood cancer
A clinical study has shown that a new protocol for stem cell or bone marrow transplantation with unmatched donors achieves outcomes comparable to patients with fully matched donors.
New drug combination shows promise for treating transplant ineligible Multiple Myeloma patients
Diagram shows signs and symptoms of Multiple Myeloma – Image credit Multiple Myeloma Foundation CANCER DIGEST – June 8, 2025 – The...
Early results show promise of CAR-T cell therapy for treating rare blood cancer
Eight of 11 patients (72.7%) treated in a early stage international clinical trial of a new drug for a rare form of blood cancer achieved complete remission, meaning there were no signs of cancer after treatment, a new study shows.
Sequence of treatment matters in second-line and third-line therapy for a certain type of blood cancer
Sequence of treatment matters in second-line and third-line therapy for a certain type of blood cancer
Danish study finds link between tattoos and lymphoma and skin cancer risk
CANCER DIGEST – March 8, 2025 – When most people get a tattoo, their health concerns center almost entirely on cleanliness and risk of...
